Lyra Therapeutics, Inc. (LYRA)

NASDAQ: LYRA · Real-Time Price · USD

0.0944

+0.0002 (0.21%)

At close: May 13, 2025, 4:00 PM

0.0950

+0.0006 (0.64%)

Pre-market: May 14, 2025, 7:00 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018
Novel Integrated Drug and Drug Delivery Solutions	1.56M	Log In	Log In	Log In
Novel Integrated Drug and Drug Delivery Solutions Growth	14.31%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018
United States	1.56M	Log In	Log In	Log In
United States Growth	14.31%	Log In	Log In	Log In